Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors), JAK inhibitors(Janus kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | 01 Mar 2019 |